Codiak BioSciences, Inc. Retained Earnings
Codiak BioSciences, Inc. had Retained Earnings of -$359.33 million as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2022-11-03
- 2022-09-30: Retained Earnings (Accumulated Deficit) -$359.33M.
- 2022-06-30: Retained Earnings (Accumulated Deficit) -$340.05M.
- 2022-03-31: Retained Earnings (Accumulated Deficit) -$333.27M.
- 2021-12-31: Retained Earnings (Accumulated Deficit) -$325.25M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2022-09-30 | -$359.33M 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$340.05M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$333.27M 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$325.25M 10-Q · filed 2022-11-03 |
| 2021-09-30 | -$341.91M 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$320.21M 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$298.40M 10-Q · filed 2021-05-06 |
| 2020-12-31 | -$288.09M 10-K · filed 2022-03-10 |
| 2020-09-30 | -$270.13M 10-Q · filed 2020-11-19 |
| 2019-12-31 | -$192.88M 10-K · filed 2021-03-17 |